 Maria Nagel
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 3, Human | 71 | 2024 | 331 | 18.640 |
Why?
| | Herpes Zoster | 44 | 2024 | 317 | 11.380 |
Why?
| | Temporal Arteries | 17 | 2021 | 45 | 5.830 |
Why?
| | Giant Cell Arteritis | 13 | 2021 | 48 | 5.300 |
Why?
| | DNA, Viral | 14 | 2024 | 349 | 3.230 |
Why?
| | Amyloid beta-Peptides | 7 | 2024 | 213 | 2.730 |
Why?
| | Cerebral Arteries | 8 | 2021 | 60 | 2.660 |
Why?
| | Encephalitis, Varicella Zoster | 9 | 2016 | 17 | 2.580 |
Why?
| | Varicella Zoster Virus Infection | 6 | 2024 | 25 | 2.430 |
Why?
| | Stroke | 10 | 2023 | 1067 | 2.280 |
Why?
| | Virus Diseases | 8 | 2022 | 211 | 2.280 |
Why?
| | Chickenpox | 12 | 2024 | 80 | 2.170 |
Why?
| | Antibodies, Viral | 11 | 2024 | 601 | 2.030 |
Why?
| | Islet Amyloid Polypeptide | 3 | 2021 | 46 | 2.010 |
Why?
| | Herpesviridae Infections | 7 | 2024 | 141 | 2.000 |
Why?
| | Varicellovirus | 7 | 2024 | 17 | 1.800 |
Why?
| | Astrocytes | 4 | 2020 | 201 | 1.670 |
Why?
| | Adventitia | 5 | 2021 | 43 | 1.550 |
Why?
| | Antiviral Agents | 14 | 2022 | 712 | 1.500 |
Why?
| | Virus Activation | 7 | 2024 | 88 | 1.450 |
Why?
| | Antigens, Viral | 6 | 2021 | 178 | 1.450 |
Why?
| | Vascular Diseases | 6 | 2014 | 241 | 1.430 |
Why?
| | Herpesvirus 1, Human | 7 | 2024 | 86 | 1.370 |
Why?
| | Gene Expression Regulation, Viral | 4 | 2019 | 90 | 1.350 |
Why?
| | Virus Latency | 8 | 2024 | 84 | 1.340 |
Why?
| | Arteritis | 2 | 2021 | 26 | 1.320 |
Why?
| | Fibroblasts | 5 | 2021 | 948 | 1.290 |
Why?
| | Adrenal Glands | 2 | 2021 | 70 | 1.230 |
Why?
| | Cerebrovascular Disorders | 3 | 2021 | 90 | 1.090 |
Why?
| | Peptide Fragments | 3 | 2024 | 691 | 1.090 |
Why?
| | Exanthema | 6 | 2022 | 74 | 1.080 |
Why?
| | B7-H1 Antigen | 2 | 2019 | 196 | 1.000 |
Why?
| | Ganglia | 4 | 2019 | 17 | 0.900 |
Why?
| | Vasculitis, Central Nervous System | 3 | 2016 | 14 | 0.860 |
Why?
| | Host-Pathogen Interactions | 4 | 2020 | 352 | 0.850 |
Why?
| | Substance P | 2 | 2020 | 43 | 0.840 |
Why?
| | Immunoglobulin G | 7 | 2024 | 845 | 0.830 |
Why?
| | Neuralgia, Postherpetic | 7 | 2014 | 40 | 0.830 |
Why?
| | Humans | 85 | 2024 | 129378 | 0.830 |
Why?
| | Nervous System Diseases | 4 | 2016 | 252 | 0.820 |
Why?
| | Optic Neuropathy, Ischemic | 5 | 2015 | 30 | 0.820 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2021 | 9 | 0.720 |
Why?
| | Amyloid | 1 | 2021 | 84 | 0.690 |
Why?
| | Cell Death | 1 | 2022 | 354 | 0.690 |
Why?
| | Protein Aggregation, Pathological | 1 | 2020 | 16 | 0.680 |
Why?
| | Antigens, CD | 2 | 2019 | 489 | 0.670 |
Why?
| | Central Nervous System Infections | 1 | 2020 | 35 | 0.660 |
Why?
| | Vascular Remodeling | 1 | 2021 | 192 | 0.650 |
Why?
| | Herpes Zoster Ophthalmicus | 2 | 2016 | 5 | 0.650 |
Why?
| | Aged, 80 and over | 17 | 2020 | 7069 | 0.640 |
Why?
| | Corneal Keratocytes | 1 | 2019 | 10 | 0.630 |
Why?
| | Meningitis | 1 | 2020 | 80 | 0.620 |
Why?
| | Epithelium, Corneal | 1 | 2019 | 40 | 0.620 |
Why?
| | Matrix Metalloproteinases | 2 | 2019 | 90 | 0.620 |
Why?
| | Receptors, Neurokinin-1 | 1 | 2018 | 12 | 0.610 |
Why?
| | Cerebral Arterial Diseases | 2 | 2015 | 48 | 0.600 |
Why?
| | Pseudopodia | 1 | 2018 | 25 | 0.600 |
Why?
| | Cells, Cultured | 8 | 2021 | 4082 | 0.600 |
Why?
| | Myofibroblasts | 1 | 2019 | 121 | 0.590 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2018 | 113 | 0.590 |
Why?
| | Aged | 25 | 2024 | 22052 | 0.590 |
Why?
| | Cadherins | 1 | 2019 | 188 | 0.580 |
Why?
| | Asymptomatic Diseases | 2 | 2016 | 84 | 0.580 |
Why?
| | Middle Aged | 27 | 2024 | 31102 | 0.580 |
Why?
| | Cytokines | 3 | 2024 | 2015 | 0.560 |
Why?
| | Male | 38 | 2024 | 63595 | 0.530 |
Why?
| | Saliva | 3 | 2016 | 209 | 0.530 |
Why?
| | Burning Mouth Syndrome | 1 | 2016 | 5 | 0.530 |
Why?
| | Spinal Cord | 2 | 2018 | 356 | 0.530 |
Why?
| | SUNCT Syndrome | 1 | 2016 | 1 | 0.520 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1706 | 0.520 |
Why?
| | Trigeminal Ganglion | 4 | 2024 | 25 | 0.520 |
Why?
| | Macaca mulatta | 5 | 2024 | 149 | 0.500 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2019 | 958 | 0.490 |
Why?
| | Interleukin-6 | 1 | 2019 | 720 | 0.490 |
Why?
| | Vasculitis | 2 | 2015 | 65 | 0.480 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2016 | 200 | 0.480 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2019 | 857 | 0.480 |
Why?
| | Tunica Intima | 2 | 2012 | 84 | 0.460 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2014 | 13 | 0.460 |
Why?
| | Acyclovir | 4 | 2020 | 99 | 0.460 |
Why?
| | Stellate Ganglion | 1 | 2014 | 4 | 0.460 |
Why?
| | Ganglia, Sympathetic | 1 | 2014 | 14 | 0.450 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 70 | 0.450 |
Why?
| | Herpesvirus 2, Human | 1 | 2014 | 28 | 0.450 |
Why?
| | Steroids | 1 | 2015 | 158 | 0.450 |
Why?
| | Zoster Sine Herpete | 2 | 2012 | 2 | 0.440 |
Why?
| | Transcription, Genetic | 3 | 2019 | 1418 | 0.420 |
Why?
| | Herpes Simplex | 3 | 2024 | 93 | 0.420 |
Why?
| | Female | 33 | 2024 | 68686 | 0.420 |
Why?
| | Aorta | 1 | 2016 | 411 | 0.420 |
Why?
| | Hippocampus | 1 | 2018 | 874 | 0.420 |
Why?
| | Transcriptome | 3 | 2021 | 887 | 0.410 |
Why?
| | Leukocyte Common Antigens | 1 | 2013 | 82 | 0.410 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2013 | 51 | 0.410 |
Why?
| | Middle Cerebral Artery | 1 | 2012 | 41 | 0.400 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2548 | 0.390 |
Why?
| | Viral Proteins | 6 | 2024 | 328 | 0.350 |
Why?
| | Open Reading Frames | 4 | 2018 | 117 | 0.350 |
Why?
| | Gene Expression | 3 | 2020 | 1471 | 0.350 |
Why?
| | RNA, Messenger | 4 | 2020 | 2707 | 0.350 |
Why?
| | Cell Movement | 3 | 2019 | 945 | 0.340 |
Why?
| | RNA, Viral | 4 | 2012 | 619 | 0.340 |
Why?
| | Pemphigus | 1 | 2009 | 8 | 0.320 |
Why?
| | B-Cell Activating Factor | 1 | 2009 | 21 | 0.320 |
Why?
| | Antigens, CD20 | 1 | 2009 | 27 | 0.320 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 428 | 0.310 |
Why?
| | Animals | 20 | 2024 | 35346 | 0.300 |
Why?
| | Primary Cell Culture | 2 | 2022 | 160 | 0.290 |
Why?
| | Inflammation | 5 | 2022 | 2735 | 0.290 |
Why?
| | Endothelium, Vascular | 1 | 2013 | 901 | 0.270 |
Why?
| | Alzheimer Disease | 2 | 2023 | 519 | 0.270 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2019 | 1056 | 0.270 |
Why?
| | Retinal Necrosis Syndrome, Acute | 3 | 2013 | 8 | 0.250 |
Why?
| | Adult | 15 | 2024 | 35512 | 0.250 |
Why?
| | Brain | 6 | 2024 | 2678 | 0.230 |
Why?
| | Lymphocyte Depletion | 2 | 2019 | 131 | 0.230 |
Why?
| | Leukocytes | 2 | 2018 | 304 | 0.230 |
Why?
| | Virus Replication | 3 | 2022 | 451 | 0.220 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 999 | 0.210 |
Why?
| | Monkey Diseases | 2 | 2024 | 20 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 7 | 2016 | 3398 | 0.200 |
Why?
| | Microglia | 1 | 2024 | 235 | 0.200 |
Why?
| | Azadirachta | 1 | 2022 | 3 | 0.200 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 130 | 0.200 |
Why?
| | B-Lymphocytes | 3 | 2013 | 815 | 0.200 |
Why?
| | Biopsy | 2 | 2016 | 1089 | 0.200 |
Why?
| | Adrenal Cortex | 1 | 2022 | 27 | 0.190 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1367 | 0.190 |
Why?
| | Exosomes | 1 | 2023 | 96 | 0.190 |
Why?
| | Tissue Fixation | 1 | 2021 | 34 | 0.190 |
Why?
| | Risk Factors | 5 | 2021 | 9752 | 0.190 |
Why?
| | Paraffin Embedding | 1 | 2021 | 29 | 0.190 |
Why?
| | Electrophoresis, Capillary | 2 | 2013 | 20 | 0.190 |
Why?
| | Macaca fascicularis | 1 | 2021 | 62 | 0.180 |
Why?
| | Viral Envelope Proteins | 2 | 2020 | 81 | 0.180 |
Why?
| | Plasma | 1 | 2023 | 206 | 0.180 |
Why?
| | Formaldehyde | 1 | 2021 | 60 | 0.180 |
Why?
| | Histological Techniques | 1 | 2021 | 40 | 0.180 |
Why?
| | Autoantibodies | 1 | 2009 | 1466 | 0.180 |
Why?
| | Cerebral Angiography | 2 | 2012 | 109 | 0.180 |
Why?
| | Immunosuppressive Agents | 2 | 2020 | 848 | 0.180 |
Why?
| | DNA, Complementary | 1 | 2021 | 270 | 0.180 |
Why?
| | Cell Line | 4 | 2020 | 2780 | 0.170 |
Why?
| | Skin | 2 | 2019 | 724 | 0.170 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 8 | 0.170 |
Why?
| | Whole-Body Irradiation | 1 | 2020 | 76 | 0.170 |
Why?
| | TRPM Cation Channels | 1 | 2021 | 77 | 0.170 |
Why?
| | Interleukins | 1 | 2022 | 241 | 0.170 |
Why?
| | Olfactory Receptor Neurons | 1 | 2021 | 68 | 0.170 |
Why?
| | Intracellular Space | 1 | 2020 | 69 | 0.160 |
Why?
| | Anti-Inflammatory Agents | 2 | 2014 | 480 | 0.160 |
Why?
| | Claudin-1 | 1 | 2019 | 21 | 0.160 |
Why?
| | Protein Aggregates | 1 | 2020 | 67 | 0.160 |
Why?
| | Prevalence | 3 | 2015 | 2560 | 0.160 |
Why?
| | Extracellular Space | 1 | 2020 | 120 | 0.160 |
Why?
| | Thrombosis | 1 | 2023 | 343 | 0.160 |
Why?
| | Culture Media, Conditioned | 1 | 2019 | 110 | 0.160 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 14 | 0.160 |
Why?
| | Case-Control Studies | 2 | 2020 | 3375 | 0.160 |
Why?
| | Tacrolimus | 1 | 2020 | 193 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 96 | 0.160 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2019 | 48 | 0.160 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2019 | 30 | 0.160 |
Why?
| | Spinal Cord Diseases | 2 | 2010 | 41 | 0.160 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2018 | 9 | 0.150 |
Why?
| | Macrophages | 3 | 2024 | 1480 | 0.150 |
Why?
| | Spiro Compounds | 1 | 2018 | 11 | 0.150 |
Why?
| | CTLA-4 Antigen | 1 | 2019 | 87 | 0.150 |
Why?
| | Diagnosis, Differential | 3 | 2013 | 1428 | 0.150 |
Why?
| | Electrochemical Techniques | 1 | 2019 | 48 | 0.150 |
Why?
| | Coculture Techniques | 1 | 2019 | 226 | 0.150 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2018 | 92 | 0.150 |
Why?
| | DNA | 3 | 2021 | 1400 | 0.150 |
Why?
| | Risk | 1 | 2020 | 854 | 0.140 |
Why?
| | Motor Neurons | 1 | 2020 | 236 | 0.140 |
Why?
| | Herpes Zoster Vaccine | 2 | 2011 | 162 | 0.140 |
Why?
| | Fatal Outcome | 2 | 2015 | 300 | 0.140 |
Why?
| | Aortic Diseases | 1 | 2018 | 115 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 232 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1196 | 0.130 |
Why?
| | Protein Isoforms | 1 | 2018 | 391 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 520 | 0.130 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5438 | 0.130 |
Why?
| | Aortitis | 1 | 2016 | 10 | 0.130 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 385 | 0.130 |
Why?
| | Virology | 2 | 2013 | 23 | 0.130 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 545 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 331 | 0.130 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2015 | 18 | 0.130 |
Why?
| | Matrix Metalloproteinase 3 | 1 | 2015 | 26 | 0.120 |
Why?
| | Neuroglia | 1 | 2016 | 168 | 0.120 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2015 | 55 | 0.120 |
Why?
| | Eye Infections, Viral | 1 | 2015 | 7 | 0.120 |
Why?
| | Histocytochemistry | 1 | 2015 | 83 | 0.120 |
Why?
| | Oxygen | 1 | 2020 | 911 | 0.120 |
Why?
| | Functional Laterality | 1 | 2016 | 222 | 0.120 |
Why?
| | Pheochromocytoma | 1 | 2016 | 57 | 0.120 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2015 | 119 | 0.120 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2016 | 84 | 0.120 |
Why?
| | Neurons | 2 | 2016 | 1511 | 0.120 |
Why?
| | STAT2 Transcription Factor | 1 | 2014 | 3 | 0.120 |
Why?
| | Vision Disorders | 2 | 2012 | 135 | 0.120 |
Why?
| | Insulin Resistance | 1 | 2023 | 1165 | 0.110 |
Why?
| | Down-Regulation | 1 | 2016 | 636 | 0.110 |
Why?
| | Internationality | 1 | 2015 | 149 | 0.110 |
Why?
| | Nanoparticles | 1 | 2018 | 374 | 0.110 |
Why?
| | Interferon-beta | 1 | 2014 | 89 | 0.110 |
Why?
| | Medulla Oblongata | 1 | 2013 | 31 | 0.110 |
Why?
| | Risk Assessment | 1 | 2023 | 3236 | 0.110 |
Why?
| | Fluorometry | 1 | 2013 | 17 | 0.110 |
Why?
| | Pons | 1 | 2013 | 30 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 63 | 0.110 |
Why?
| | Age Factors | 2 | 2014 | 3144 | 0.110 |
Why?
| | Polyethylene Glycols | 1 | 2018 | 601 | 0.100 |
Why?
| | Intracranial Aneurysm | 1 | 2014 | 95 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 345 | 0.100 |
Why?
| | Interferon-alpha | 1 | 2014 | 194 | 0.100 |
Why?
| | Dementia, Multi-Infarct | 1 | 2012 | 1 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1037 | 0.100 |
Why?
| | Myelitis | 1 | 2014 | 98 | 0.100 |
Why?
| | Blood Vessels | 1 | 2014 | 187 | 0.100 |
Why?
| | Olfactory Mucosa | 2 | 2024 | 64 | 0.100 |
Why?
| | Protein Transport | 1 | 2014 | 428 | 0.100 |
Why?
| | Optic Nerve | 1 | 2012 | 64 | 0.100 |
Why?
| | Methylprednisolone | 1 | 2012 | 83 | 0.100 |
Why?
| | RNA | 1 | 2019 | 883 | 0.100 |
Why?
| | Apoptosis | 2 | 2019 | 2503 | 0.090 |
Why?
| | Facial Paralysis | 1 | 2011 | 17 | 0.090 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1698 | 0.090 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 55 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2391 | 0.090 |
Why?
| | Fetus | 1 | 2015 | 772 | 0.090 |
Why?
| | Hyperplasia | 1 | 2011 | 171 | 0.090 |
Why?
| | Cerebrospinal Fluid | 1 | 2011 | 90 | 0.090 |
Why?
| | MicroRNAs | 2 | 2024 | 678 | 0.090 |
Why?
| | RNA Stability | 1 | 2011 | 100 | 0.080 |
Why?
| | Myosin Heavy Chains | 1 | 2011 | 170 | 0.080 |
Why?
| | Herpes Zoster Oticus | 1 | 2010 | 2 | 0.080 |
Why?
| | Adolescent | 4 | 2024 | 20378 | 0.080 |
Why?
| | Comorbidity | 1 | 2015 | 1546 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1083 | 0.080 |
Why?
| | Immunocompromised Host | 1 | 2011 | 197 | 0.080 |
Why?
| | Phosphorylation | 1 | 2014 | 1713 | 0.080 |
Why?
| | Cranial Nerve Diseases | 1 | 2010 | 41 | 0.080 |
Why?
| | Neural Stem Cells | 1 | 2011 | 143 | 0.080 |
Why?
| | Receptors, CCR1 | 1 | 2009 | 4 | 0.080 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2009 | 3 | 0.080 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2011 | 259 | 0.080 |
Why?
| | Lung | 3 | 2019 | 3919 | 0.080 |
Why?
| | Biomarkers | 1 | 2020 | 3972 | 0.080 |
Why?
| | Actins | 1 | 2011 | 411 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2016 | 2714 | 0.080 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 87 | 0.080 |
Why?
| | History, 21st Century | 1 | 2009 | 182 | 0.080 |
Why?
| | Laboratories | 1 | 2009 | 109 | 0.070 |
Why?
| | Spectrometry, Fluorescence | 1 | 2009 | 171 | 0.070 |
Why?
| | History, 20th Century | 1 | 2009 | 290 | 0.070 |
Why?
| | Rituximab | 1 | 2009 | 162 | 0.070 |
Why?
| | DNA Primers | 1 | 2009 | 510 | 0.070 |
Why?
| | Neutrophils | 1 | 2012 | 1205 | 0.070 |
Why?
| | Chickenpox Vaccine | 1 | 2007 | 71 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2142 | 0.070 |
Why?
| | Spinal Cord Ischemia | 1 | 2007 | 56 | 0.070 |
Why?
| | Pain | 1 | 2012 | 785 | 0.070 |
Why?
| | Antidepressive Agents | 1 | 2008 | 228 | 0.070 |
Why?
| | Incidence | 1 | 2013 | 2641 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2831 | 0.060 |
Why?
| | Registries | 1 | 2014 | 1888 | 0.060 |
Why?
| | Analgesics | 1 | 2007 | 186 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2011 | 1945 | 0.060 |
Why?
| | Time Factors | 3 | 2014 | 6550 | 0.060 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4061 | 0.060 |
Why?
| | Substance-Related Disorders | 1 | 2014 | 1022 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5061 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1928 | 0.060 |
Why?
| | Disease Progression | 4 | 2014 | 2626 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1835 | 0.060 |
Why?
| | Recurrence | 2 | 2021 | 1005 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2011 | 1901 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 103 | 0.050 |
Why?
| | Mice | 4 | 2024 | 16935 | 0.050 |
Why?
| | Presenilin-1 | 1 | 2022 | 31 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2528 | 0.050 |
Why?
| | Central Nervous System | 1 | 2024 | 257 | 0.050 |
Why?
| | Fructose | 1 | 2023 | 106 | 0.050 |
Why?
| | Limonins | 1 | 2022 | 2 | 0.050 |
Why?
| | Plant Bark | 1 | 2022 | 11 | 0.050 |
Why?
| | Uric Acid | 1 | 2023 | 161 | 0.050 |
Why?
| | Young Adult | 2 | 2024 | 12415 | 0.050 |
Why?
| | Olfactory Bulb | 1 | 2022 | 136 | 0.040 |
Why?
| | Signal Transduction | 1 | 2014 | 4924 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2008 | 913 | 0.040 |
Why?
| | Plant Extracts | 1 | 2022 | 199 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 235 | 0.040 |
Why?
| | Infant | 2 | 2024 | 9023 | 0.040 |
Why?
| | Neuroimaging | 1 | 2021 | 279 | 0.040 |
Why?
| | Child, Preschool | 2 | 2024 | 10516 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 248 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2018 | 315 | 0.040 |
Why?
| | Mice, SCID | 1 | 2018 | 351 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 1002 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 221 | 0.030 |
Why?
| | Plasmids | 1 | 2018 | 358 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2018 | 163 | 0.030 |
Why?
| | Action Potentials | 1 | 2020 | 486 | 0.030 |
Why?
| | Child | 3 | 2024 | 20868 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2019 | 469 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1062 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2119 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 478 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1245 | 0.030 |
Why?
| | Mitochondria | 1 | 2020 | 877 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 118 | 0.030 |
Why?
| | Visual Acuity | 1 | 2015 | 322 | 0.030 |
Why?
| | Basal Ganglia Cerebrovascular Disease | 1 | 2012 | 3 | 0.030 |
Why?
| | Apraxias | 1 | 2012 | 7 | 0.030 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2012 | 8 | 0.030 |
Why?
| | Pupil Disorders | 1 | 2012 | 5 | 0.030 |
Why?
| | Dysarthria | 1 | 2012 | 9 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 387 | 0.030 |
Why?
| | Postmortem Changes | 1 | 2012 | 16 | 0.030 |
Why?
| | Immediate-Early Proteins | 1 | 2012 | 52 | 0.020 |
Why?
| | Valine | 1 | 2012 | 81 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2012 | 229 | 0.020 |
Why?
| | Gait Disorders, Neurologic | 1 | 2012 | 44 | 0.020 |
Why?
| | Prednisone | 1 | 2012 | 233 | 0.020 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2011 | 14 | 0.020 |
Why?
| | Thiouridine | 1 | 2011 | 1 | 0.020 |
Why?
| | Phosphonoacetic Acid | 1 | 2011 | 10 | 0.020 |
Why?
| | Memory Disorders | 1 | 2012 | 168 | 0.020 |
Why?
| | Subarachnoid Space | 1 | 2011 | 8 | 0.020 |
Why?
| | Thalamus | 1 | 2012 | 100 | 0.020 |
Why?
| | Half-Life | 1 | 2011 | 162 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 235 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 376 | 0.020 |
Why?
| | Alphaherpesvirinae | 1 | 2009 | 1 | 0.020 |
Why?
| | Vero Cells | 1 | 2009 | 65 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 1039 | 0.020 |
Why?
| | Immunization | 1 | 2011 | 411 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 978 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 642 | 0.020 |
Why?
| | HeLa Cells | 1 | 2009 | 608 | 0.020 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2007 | 35 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2007 | 96 | 0.020 |
Why?
| | Paralysis | 1 | 2007 | 69 | 0.020 |
Why?
| | Treatment Failure | 1 | 2007 | 339 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1713 | 0.020 |
Why?
| | Arteries | 1 | 2007 | 264 | 0.020 |
Why?
| | Neoplasms | 1 | 2018 | 2469 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3215 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3717 | 0.010 |
Why?
|
|
Nagel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|